查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球合成生物学市场：按工具、技术和应用划分 - 预测（~2029 年）
市场调查报告书
商品编码
1590393

全球合成生物学市场：按工具、技术和应用划分 - 预测（~2029 年）

Synthetic Biology Market by Tools, Technology, Applications - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 537 Pages | 订单完成后即时交付

价格

全球合成生物学市场规模预计将从2024年的123.3亿美元增加到2029年的315.2亿美元，复合年增长率高达20.6%。

对生物基产品的过度需求正在推动市场成长。此外，主要市场参与者增加投资以满足国内和国际市场需求以及增加合成生物学市场研发和合作研究的资金正在进一步推动市场成长。包括 CRISPR 在内的基因编辑技术的发展为合成生物学领域开闢了新的途径。这些先进技术实现了精确的基因改造，加速了治疗应用和农业的进步，并推动了合成生物学市场的成长。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
单元 美元
部分 工具、技术和应用
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

“寡核苷酸/合成DNA合成生物学领域在2023年占了最高份额。”

寡核苷酸和合成 DNA 占据市场主导地位，预计在预测期内将以显着的复合年增长率成长。寡核苷酸和合成DNA在环境、食品和工业领域的使用不断增加，以及合成生物学公司在农业、能源和工业生物技术等领域的扩张，是细分市场成长的关键驱动力。

“按应用来看，医疗应用领域占据了最大的市场份额。”

随着慢性病和遗传疾病的增加增加了对创新医疗解决方案的需求，医疗应用占据了市场占有率。此外，基因编辑和合成微生物的进步使研究人员能够开发标靶治疗、个人化医疗，甚至工程疫苗。

“北美：合成生物学市场份额最大”

预计北美将在 2023 年主导合成生物学市场，并在预测期内保持其主导地位。该地区製药和生物技术公司等领先市场参与者的存在以及 Thermo Fisher Scientific Inc. 和 Agilent Technologies Inc. 等合成生物学製造商的强大基础是市场成长的重要推动力。

本报告研究和分析了全球合成生物学市场，提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

  • 合成生物市场概况
  • 北美合成生物市场：按应用、按国家划分（2023 年）
  • 合成生物学市场占有率：依应用分类（2024/2029）
  • 合成生物市场：按地区

第五章市场概况

  • 介绍
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 影响客户业务的趋势/干扰
  • 价值链分析
  • 生态系分析
    • 产品/服务供应商
    • 最终用户
    • 监管环境
  • 技术分析
    • 主要技术
    • 互补技术
    • 邻近技术
  • 专利分析
    • 调查方法
    • 专利申请数量
    • 创新和专利申请
  • 价格分析
    • 产品参考价格分析：依主要企业分类
    • 产品参考价格分析：按地区
  • 重大会议和活动（2024-2025）
  • 监管环境
    • 监管机构、政府机构和其他组织
    • 法规结构
  • 投资金筹措场景
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 人工智慧对合成生物学市场的影响

第六章合成生物市场：依工具分类

  • 介绍
  • 寡核苷酸/合成DNA
  • 酵素
  • 克隆技术套件
  • 合成细胞
  • 底盘有机体
  • 异源核酸

第七章合成生物市场：依技术分类

  • 介绍
  • 基因合成
  • 基因组工程
  • 定序
  • 生物资讯学
  • 复製
  • 特异性诱变
  • 测量/建模
  • 微流体
  • 奈米科技

第八章合成生物市场：依应用分类

  • 介绍
  • 医疗用途
    • 药品
    • 药物发现/治疗
    • 人工组织/组织再生
  • 工业用途
    • 生质燃料/可再生能源
    • 工业酵素
    • 生医材料/绿色化学品
  • 食品、兽药、农业应用
    • 香味
    • 其他食品、兽医和农业用途
  • 环境应用
    • 生物修復
    • 生物感

第九章合成生物市场：按地区

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 瑞士
    • 丹麦
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东
    • 中东宏观经济展望
    • 海湾合作委员会国家
    • 其他中东地区
  • 非洲

第10章竞争格局

  • 概述
  • 主要企业策略/主要企业
  • 收益分析
  • 市场占有率分析
  • 企业评价矩阵：主要企业（2023年）
  • 企业评估矩阵：Start-Ups/中小企业（2023）
  • 企业评价及财务指标（2023年）
  • 品牌/产品比较
  • 竞争场景

第十一章 公司简介

  • 主要企业
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • NOVOZYMES A/S
    • EUROFINS SCIENTIFIC
    • AGILENT TECHNOLOGIES INC.
    • AMYRIS, INC.
    • CODEXIS, INC.
    • TWIST BIOSCIENCE
    • GENSCRIPT
    • PRECIGEN
    • GINKGO BIOWORKS
    • VIRIDOS
    • SYNTHEGO
    • CREATIVE ENZYMES
    • CYRUS BIOTECHNOLOGY
  • 其他公司
    • ATUM
    • TESELAGEN
    • ARZEDA
    • INTEGRATED DNA TECHNOLOGIES, INC.
    • NEW ENGLAND BIOLABS
    • ELEVATEBIO
    • ZENFOLD (IOSYNTH)
    • SYNBIO TECHNOLOGIES
    • INSCRIPTA, INC.
    • CRISPR THERAPEUTICS

第十二章附录

Product Code: BT 2910

The global synthetic biology market is projected to surpass USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%. The excessive demand for bio-based products is providing momentum to the market growth. Furthermore, rising investment by key market players and increasing funding in R&D & collaborations in the synthetic biology market to meet the needs of both local and international markets is further driving the market growth. The development of CRISPR and other gene-editing technologies opened new avenues for the synthetic biology sector. These advanced technologies enable precise gene modifications, accelerating advancements in therapeutic applications and agriculture fueling the growth of the synthetic biology market.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Tools, Technology and Application
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The oligonucleotide & synthetic DNA synthetic biology segment accounted for the highest share in 2023."

On the basis of tools, the synthetic biology market is further segmented into xeno nucleic acids, enzymes, chassis organisms, cloning technology kits, oligonucleotides and synthetic DNA, and synthetic cells. The oligonucleotides and synthetic DNA dominated the market and anticipated to grow at a significant CAGR during the forecast period. Rise in the use of oligonucleotides and synthetic DNA in environmental, food, and industrial sectors, expansion of synthetic biology companies in in areas such as agriculture, energy, and industrial biotechnology are some of the major factors driving the segmental growth.

"By applications, medical applications segment accounted for the largest share in the synthetic biology market."

The applications segment in the synthetic biology market is segmented into medical applications, industrial applications, food, animal health & agricultural applications and environmental applications. The medical applications segment dominated the market share owing to the increasing prevalence of chronic diseases and genetic disorders which is driving demand for innovative medical solutions. Furthermore, with advancements in gene editing and synthetic microbes, researchers can develop targeted therapies, personalized medicine, and even engineered vaccines.

"North America: the largest share of the synthetic biology market"

By region, the market is segment into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America dominated the synthetic biology market in 2023 and is estimated to continue dominance during the forecast period. Presence of dominant market players in pharmaceutical and biotechnological companies in the region, strong base of synthetic biology manufacturers such as Thermo Fisher Scientific Inc. and Agilent Technologies Inc. are some of the prominent factors acerating market growth.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the synthetic biology market.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Novozymes A/S (Denmark), Agilent Technologies Inc. (US), Eurofins Scientific (Luxembourg), Amyris, Inc. (US), Twist Bioscience (US), Codexis, Inc. (US), Genscript (US), Ginkgo Bioworks (US), Precigen (US), Creative Enzymes (US), Synthego (US), Viridos (US), and Cyrus Biotechnology (US) are some of the major players operating in the synthetic biology market.

Research Coverage:

This research report categorizes the synthetic biologys market tools (oligonucleotides & synthetic DNA, enzymes, cloning technology kits, chassis organisms, xeno nucleic acids and synthetic cells), technologies (measurement and modeling, genome engineering, gene synthesis, cloning, site-directed mutagenesis, microfluidics, sequencing, nanotechnology and bioinformatics), and applications (medical applications, industrial applications, food, animal health & agricultural applications and environmental applications) and region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the synthetic biologys market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the synthetic biology market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the synthetic biology and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (diverse applications of synthetic biology, increasing demand for bio-based products, advancements in synthetic biology, rising funding in R&D and collaborations), restraints (production scalability, ethical and regulatory challenges), opportunities (rising opportunities for agricultural synthetic biology, growing use of artificial intelligence and machine learning) and Challenges (Cost constraints) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on upcoming technologies in synthetic biology manufacturing, research and development activities, and new product launches in the synthetic biology market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the synthetic biology market
  • Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Novozymes A/S (Denmark), Eurofins Scientific (Luxembourg), Agilent Technologies Inc. (US), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 MARKET SIZE ESTIMATION
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • 2.2.3 TOP-DOWN APPROACH
  • 2.3 MARKET GROWTH RATE PROJECTION
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW
  • 4.2 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION AND COUNTRY (2023)
  • 4.3 SYNTHETIC BIOLOGY MARKET SHARE, BY APPLICATION, 2024 VS. 2029
  • 4.4 SYNTHETIC BIOLOGY MARKET, BY REGION

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Diverse applications of synthetic biology
      • 5.2.1.2 Surging demand for bio-based products
      • 5.2.1.3 Advancements in synthetic biology
      • 5.2.1.4 Increasing funding in R&D and collaborations
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Production scalability
      • 5.2.2.2 Ethical and regulatory challenges
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising opportunities for agricultural synthetic biology
      • 5.2.3.2 Growing integration of artificial intelligence and machine learning
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Cost constraints
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • 5.5.1 PRODUCT/SERVICE PROVIDERS
    • 5.5.2 END USERS
    • 5.5.3 REGULATORY LANDSCAPE
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 KEY TECHNOLOGIES
      • 5.6.1.1 DNA synthesis and sequencing
      • 5.6.1.2 Gene editing tools
      • 5.6.1.3 Bioinformatics and computational tools
      • 5.6.1.4 Nanotechnology
    • 5.6.2 COMPLEMENTARY TECHNOLOGIES
      • 5.6.2.1 Cellular and tissue engineering
    • 5.6.3 ADJACENT TECHNOLOGIES
      • 5.6.3.1 Metabolic engineering
  • 5.7 PATENT ANALYSIS
    • 5.7.1 METHODOLOGY
    • 5.7.2 NUMBER OF PATENTS FILED
    • 5.7.3 INNOVATION AND PATENT APPLICATIONS
  • 5.8 PRICING ANALYSIS
    • 5.8.1 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER
    • 5.8.2 INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION
  • 5.9 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.2 REGULATORY FRAMEWORK
  • 5.11 INVESTMENT & FUNDING SCENARIO
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.12.2 BARGAINING POWER OF SUPPLIERS
    • 5.12.3 BARGAINING POWER OF BUYERS
    • 5.12.4 THREAT OF SUBSTITUTES
    • 5.12.5 THREAT OF NEW ENTRANTS
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY BUYING CRITERIA
  • 5.14 IMPACT OF AI ON SYNTHETIC BIOLOGY MARKET

6 SYNTHETIC BIOLOGY MARKET, BY TOOL

  • 6.1 INTRODUCTION
  • 6.2 OLIGONUCLEOTIDES & SYNTHETIC DNA
    • 6.2.1 SURGING DEMAND FOR SYNTHETIC GENES TO SUPPORT MARKET GROWTH
  • 6.3 ENZYMES
    • 6.3.1 WIDE POTENTIAL OF ENZYME ENGINEERING IN OMICS STUDIES TO PROPEL MARKET
  • 6.4 CLONING TECHNOLOGY KITS
    • 6.4.1 ALTERATION AND OPTIMIZATION OF GENETIC CIRCUIT DESIGNS BY MOLECULAR BIOLOGY TECHNIQUES TO DRIVE MARKET
  • 6.5 SYNTHETIC CELLS
    • 6.5.1 GROWING POPULARITY OF SYNTHETIC CELLS AS SUBSTITUTES FOR NATURAL CELLS TO BOOST MARKET GROWTH
  • 6.6 CHASSIS ORGANISMS
    • 6.6.1 INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL MARKET
  • 6.7 XENO NUCLEIC ACIDS
    • 6.7.1 SPIKE IN DEMAND FOR BREAKTHROUGH MEDICINES TO AID MARKET GROWTH

7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 GENE SYNTHESIS
    • 7.2.1 RISING DEMAND FOR SYNTHETIC GENES AND INCREASING COMPETITIVENESS AMONG MARKET PLAYERS TO SPUR MARKET GROWTH
  • 7.3 GENOME ENGINEERING
    • 7.3.1 SURGING NEED FOR RAPID, CHEAP, AND MULTIPLEX MODIFICATION OF GENOMES TO DRIVE MARKET
  • 7.4 SEQUENCING
    • 7.4.1 RISING ADOPTION OF SEQUENCING TECHNOLOGY TO BOOST MARKET GROWTH
  • 7.5 BIOINFORMATICS
    • 7.5.1 INCREASING ADVANCEMENTS AND RISING USE OF BIOINFORMATICS TO PROPEL MARKET GROWTH
  • 7.6 CLONING
    • 7.6.1 PRECISE GENETIC REPLICATION TO ACCELERATE RESEARCH AND SCALING APPLICATIONS ACROSS VARIOUS INDUSTRIES
  • 7.7 SITE-DIRECTED MUTAGENESIS
    • 7.7.1 WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES TO DRIVE MARKET
  • 7.8 MEASUREMENT & MODELING
    • 7.8.1 INCREASING DEMAND FOR CELL-FREE SYNTHETIC BIOLOGY TO FOSTER MARKET GROWTH
  • 7.9 MICROFLUIDICS
    • 7.9.1 RISING FOCUS ON INCREASING SCALABILITY OF SYNTHETIC BIOLOGY TOOLS TO PROPEL MARKET GROWTH
  • 7.10 NANOTECHNOLOGY
    • 7.10.1 CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY TO AID MARKET GROWTH

8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 MEDICAL APPLICATIONS
    • 8.2.1 PHARMACEUTICALS
      • 8.2.1.1 Potential of synthetic biology techniques in development of active pharmaceutical ingredients to drive market
    • 8.2.2 DRUG DISCOVERY & THERAPEUTICS
      • 8.2.2.1 Cancer detection & diagnostics
        • 8.2.2.1.1 Increasing investments in cancer research to support market growth
      • 8.2.2.2 Other drug discovery & therapeutic applications
    • 8.2.3 ARTIFICIAL TISSUE & TISSUE REGENERATION
      • 8.2.3.1 Biosynthesis
        • 8.2.3.1.1 Expansive design space enabled by synthetic biology to foster market growth
      • 8.2.3.2 Stem cell regulation
        • 8.2.3.2.1 Stem cell research to accelerate market growth
      • 8.2.3.3 Other artificial tissue & tissue regeneration applications
  • 8.3 INDUSTRIAL APPLICATIONS
    • 8.3.1 BIOFUELS & RENEWABLE ENERGY
      • 8.3.1.1 Advantages of using genetically engineered organisms for synthetic production of biofuels to propel market growth
    • 8.3.2 INDUSTRIAL ENZYMES
      • 8.3.2.1 Textile industry
        • 8.3.2.1.1 Surge in demand for increasing reaction rates and reducing costs to foster market growth
      • 8.3.2.2 Paper industry
        • 8.3.2.2.1 Increasing use of enzymes in pulp and paper industry to favor market growth
      • 8.3.2.3 Consumer care industry
        • 8.3.2.3.1 Skincare & cosmetics
          • 8.3.2.3.1.1 Benefits offered by synthetic biology technologies in manufacturing of skincare and cosmetic products to propel market growth
        • 8.3.2.3.2 Other consumer care products
      • 8.3.2.4 Other industries
    • 8.3.3 BIOMATERIALS & GREEN CHEMICALS
      • 8.3.3.1 Production of green chemicals through microbial fermentation to drive market
  • 8.4 FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS
    • 8.4.1 FLAVORS & FRAGRANCES
      • 8.4.1.1 Rising demand for natural, sustainable products to bolster market growth
    • 8.4.2 OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS
  • 8.5 ENVIRONMENTAL APPLICATIONS
    • 8.5.1 BIOREMEDIATION
      • 8.5.1.1 Increasing need for cost-effective, on-site environmental monitoring methods to boost market
    • 8.5.2 BIOSENSING
      • 8.5.2.1 Growing interest in development of whole-cell biosensors to drive market

9 SYNTHETIC BIOLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 9.2.2 US
      • 9.2.2.1 Rising investment in synthetic biology companies and surging demand for bio-based products to drive market
    • 9.2.3 CANADA
      • 9.2.3.1 Strong research infrastructure and availability of funding to support market growth
  • 9.3 EUROPE
    • 9.3.1 EUROPE: MACROECONOMIC OUTLOOK
    • 9.3.2 GERMANY
      • 9.3.2.1 Government initiatives and increasing funding to propel market growth
    • 9.3.3 UK
      • 9.3.3.1 Increasing R&D expenditure to favor market growth
    • 9.3.4 FRANCE
      • 9.3.4.1 Investments aimed at increasing research in various biomedical fields to augment market growth
    • 9.3.5 SWITZERLAND
      • 9.3.5.1 Established biotech ecosystem, strong academic institutions, and favorable government policies to favor market growth
    • 9.3.6 DENMARK
      • 9.3.6.1 Presence of third-largest commercial drug development pipeline in Europe to favor market growth
    • 9.3.7 ITALY
      • 9.3.7.1 Increasing life sciences R&D funded by both public and private organizations to foster market
    • 9.3.8 SPAIN
      • 9.3.8.1 Well-established network of research centers, universities, and hospitals to support market growth
    • 9.3.9 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 9.4.2 CHINA
      • 9.4.2.1 Rising growth opportunities for pharmaceutical and biopharmaceutical companies to drive market
    • 9.4.3 JAPAN
      • 9.4.3.1 Growing awareness of synthetic biology's importance and potential applications to accelerate market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing R&D activities and government funding initiatives to bolster market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing funding for synthetic biology research to accelerate market growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Increasing focus on developing biotechnology and pharmaceutical sectors to boost market
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 9.5.2 BRAZIL
      • 9.5.2.1 Growing life sciences and pharmaceutical industry to fuel demand for synthetic biological products
    • 9.5.3 MEXICO
      • 9.5.3.1 Increasing support for biotechnology infrastructure development to augment market growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST
    • 9.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 KSA
      • 9.6.2.2 UAE
      • 9.6.2.3 Rest of GCC countries
    • 9.6.3 REST OF MIDDLE EAST
  • 9.7 AFRICA
    • 9.7.1 AFRICA: MACROECONOMIC OUTLOOK

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SYNTHETIC BIOLOGY MARKET
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Tool footprint
      • 10.5.5.4 Technology footprint
      • 10.5.5.5 Application footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS, 2023
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 THERMO FISHER SCIENTIFIC INC.
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products/Services offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches
        • 11.1.1.3.2 Deals
        • 11.1.1.3.3 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Key strengths
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 MERCK KGAA
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products/Services offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Key strengths
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 NOVOZYMES A/S
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products/Services offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Key strengths
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 EUROFINS SCIENTIFIC
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products/Services offered
    • 11.1.5 AGILENT TECHNOLOGIES INC.
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products/Services offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Products launches
        • 11.1.5.3.2 Deals
        • 11.1.5.3.3 Expansions
    • 11.1.6 AMYRIS, INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products/Services offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Deals
    • 11.1.7 CODEXIS, INC.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products/Services offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches
        • 11.1.7.3.2 Deals
        • 11.1.7.3.3 Expansions
    • 11.1.8 TWIST BIOSCIENCE
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products/Services offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product launches
        • 11.1.8.3.2 Deals
        • 11.1.8.3.3 Expansions
    • 11.1.9 GENSCRIPT
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products/Services offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product launches
        • 11.1.9.3.2 Deals
        • 11.1.9.3.3 Other developments
    • 11.1.10 PRECIGEN
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products/Services offered
    • 11.1.11 GINKGO BIOWORKS
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products/Services offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Product launches
        • 11.1.11.3.2 Deals
    • 11.1.12 VIRIDOS
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products/Services offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Product launches
        • 11.1.12.3.2 Deals
        • 11.1.12.3.3 Other developments
    • 11.1.13 SYNTHEGO
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products/Services offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product launches
        • 11.1.13.3.2 Deals
        • 11.1.13.3.3 Expansions
    • 11.1.14 CREATIVE ENZYMES
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products/Services offered
    • 11.1.15 CYRUS BIOTECHNOLOGY
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products/Services offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Deals
  • 11.2 OTHER PLAYERS
    • 11.2.1 ATUM
    • 11.2.2 TESELAGEN
    • 11.2.3 ARZEDA
    • 11.2.4 INTEGRATED DNA TECHNOLOGIES, INC.
    • 11.2.5 NEW ENGLAND BIOLABS
    • 11.2.6 ELEVATEBIO
    • 11.2.7 ZENFOLD (IOSYNTH)
    • 11.2.8 SYNBIO TECHNOLOGIES
    • 11.2.9 INSCRIPTA, INC.
    • 11.2.10 CRISPR THERAPEUTICS

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 SYNTHETIC BIOLOGY MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 4 KEY END USERS IN SYNTHETIC BIOLOGY MARKET
  • TABLE 5 KEY REGULATORY BODIES IN SYNTHETIC BIOLOGY MARKET
  • TABLE 6 NUMBER OF PATENTS FILED IN SYNTHETIC BIOLOGY MARKET, BY DOCUMENT TYPE, 2014-2024
  • TABLE 7 DETAILED ANALYSIS OF KEY PATENTS IN SYNTHETIC BIOLOGY MARKET, 2024
  • TABLE 8 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER, 2023
  • TABLE 9 INDICATIVE PRICING ANALYSIS OF SYNTHETIC BIOLOGY TOOLS, BY REGION, 2023
  • TABLE 10 KEY CONFERENCES & EVENTS, JUNE 2024-DECEMBER 2025
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
  • TABLE 17 SYNTHETIC BIOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • TABLE 19 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 20 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022-2029 (USD MILLION)
  • TABLE 21 SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 22 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 23 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 25 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 29 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 64 SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 79 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 SYNTHETIC BIOLOGY MARKET FOR CLONING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 98 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 120 SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 128 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 149 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 150 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 152 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 156 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 167 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 170 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 171 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 174 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 177 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 178 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 181 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 182 EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 184 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 185 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 186 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 187 SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 188 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 189 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 192 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 193 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 194 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 196 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 200 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 201 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 202 SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 206 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 209 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022-2029 (USD MILLION)
  • TABLE 210 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 211 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 212 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 214 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 215 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 217 SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 218 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 222 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 224 SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 225 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 226 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 227 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 228 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 229 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 230 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 231 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 233 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 234 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 237 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 239 SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 240 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 241 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 243 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 244 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 245 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 246 SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 247 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 248 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 250 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 251 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 253 SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 254 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 255 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 256 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 257 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 258 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 259 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 260 SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 261 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 262 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 263 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 264 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 265 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 267 SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 269 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 270 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 272 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 274 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 275 SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 276 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 277 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 278 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 279 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 280 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 282 SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 283 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 284 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 285 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 286 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 287 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 288 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 289 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 291 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)

List of Figures

  • FIGURE 1 SYNTHETIC BIOLOGY MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARIES: SYNTHETIC BIOLOGY MARKET
  • FIGURE 4 SYNTHETIC BIOLOGY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 5 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 SYNTHETIC BIOLOGY MARKET: CAGR PROJECTION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF SYNTHETIC BIOLOGY MARKET (2024-2029)
  • FIGURE 15 ADVANCEMENTS IN SYNTHETIC BIOLOGY AND RISING DEMAND FOR BIO-BASED PRODUCTS TO DRIVE MARKET
  • FIGURE 16 MEDICAL APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 17 MEDICAL APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 18 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 19 SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 21 SYNTHETIC BIOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 SYNTHETIC BIOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 SYNTHETIC BIOLOGY MARKET: PATENT ANALYSIS, 2013-2023
  • FIGURE 24 SYNTHETIC BIOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 27 NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET, 2019-2023 (USD MILLION)
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET, 2023
  • FIGURE 31 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 32 SYNTHETIC BIOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 33 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 34 EV/EBITDA OF KEY VENDORS, 2023
  • FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 36 SYNTHETIC BIOLOGY MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 39 NOVOZYMES A/S: COMPANY SNAPSHOT (2023)
  • FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 42 CODEXIS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 43 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2023)
  • FIGURE 44 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 45 PRECIGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 46 GINKGO BIOWORKS: COMPANY SNAPSHOT (2023)